The results indicate that the presence of activated virus-specific CD4+ T cells protects the mice from the development of TMEV-induced demyelinating disease, whereas naive virus-specific CD4+ T cells promote the pathogenesis (Figure 3B). Here, CD4 is linked to demyelinating disease.